XML 62 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings per Share
Earnings Per Share
For the years ended December 31
(In millions, except per share amounts)202320222021
Numerator:
Net income from continuing operations$1,618 $1,949 $2,275 
Net (income) loss attributable to noncontrolling interests(46)(51)(46)
Net income from continuing operations attributable to GE HealthCare
1,572 1,898 2,229 
Deemed preferred stock dividend of redeemable noncontrolling interest(183)— — 
Net income from continuing operations attributable to GE HealthCare common stockholders
1,389 1,898 2,229 
Income (loss) from discontinued operations, net of taxes
(4)18 18 
Net income attributable to GE HealthCare common stockholders$1,385 $1,916 $2,247 
Denominator:
Basic weighted-average shares outstanding455 454 454 
Dilutive effect of common stock equivalents— — 
Diluted weighted-average shares outstanding458 454 454 
Basic Earnings Per Share:
Continuing operations$3.06 $4.18 $4.91 
Discontinued operations(0.01)0.04 0.04 
Attributable to GE HealthCare common stockholders3.05 4.22 4.95 
Diluted Earnings Per Share:
Continuing operations$3.04 $4.18 $4.91 
Discontinued operations(0.01)0.04 0.04 
Attributable to GE HealthCare common stockholders3.03 4.22 4.95 
Antidilutive securities(1)
— — 
(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.